Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
- Resource Type
- Article
- Source
- In
The Lancet Diabetes & Endocrinology September 2023 11(9):644-656 - Subject
Primary Research Articles - Language
- ISSN
- 2213-8587